Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dyslipidaemia v0.10 | CETP | Bryony Thompson Marked gene: CETP as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyslipidaemia v0.10 | CETP | Bryony Thompson Gene: cetp has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyslipidaemia v0.10 | CETP | Bryony Thompson Classified gene: CETP as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyslipidaemia v0.10 | CETP | Bryony Thompson Added comment: Comment on list classification: Benign metabolic condition | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyslipidaemia v0.10 | CETP | Bryony Thompson Gene: cetp has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyslipidaemia v0.9 | CETP |
Bryony Thompson gene: CETP was added gene: CETP was added to Dyslipidaemia. Sources: Literature Mode of inheritance for gene: CETP was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: CETP were set to 12070157; 2586614; 27604308; 2215607; 2390095 Phenotypes for gene: CETP were set to Hyperalphalipoproteinemia MIM#143470; Disorders of high density lipoprotein metabolism Review for gene: CETP was set to GREEN Added comment: CETP deficiency causes mildly elevated HDL-cholesterol in heterozygotes and elevated HDL-cholesterol in biallelic carriers. Variants are mostly associated with a benign phenotype. Sources: Literature |